Health articles

HIV response: Pathway to success revealed

By Henry Opondo Campaigns to encourage HIV testing, particularly among groups that are most affected, free and easy access to treatment at the time of diagnosis with HIV and scale-up of evidence-based HIV prevention, such as voluntary medical male circumcision, pre-exposure prophylaxis and harm reduction have been attributed to lowering of HIV incidences and mortalities

New studies inform WHO’s decision on the use of dolutegravir in women of childbearing age  

The safety of the HIV treatment drug, dolutegravir (DTG), during pregnancy has been one of the most urgent questions in global health for the past year. At the 22nd International AIDS Conference (AIDS 2018) last year, data from the Tsepamo study in Botswana suggested that the use of DTG in early pregnancy may be linked

ECHO study finds high rates of HIV and STIs among young women in 4 African countries

Henry Opondo New evidence from eSwatini, Kenya, South Africa and Zambia presented at the 10th IAS Conference on HIV Science (IAS 2019) in Mexico show high rates of HIV incidence overall among young women in these countries. The highly-publicized Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial, which just a few weeks ago finally

Ebola response, too little, too late!

The AIDS Healthcare Foundation (AHF) has called on the Director-General of the World Health Organization Dr Tedros Adhanom Ghebreyesus to demonstrate resolute leadership on Ebola or resign. The call, coming shortly after the WHO finally declared a Public Health Emergency of International Concern (PHEIC) in the Democratic Republic of the Congo on July 17 wants the

More countries demand Child-Friendly Medicines first launched in Kenya

TB Alliance Tuesday announced that one million treatment courses of child-friendly tuberculosis (TB) medicines have been ordered by 93 countries in the three years since the introduction of the products. The new medicines, which were first introduced nationally in Kenya in September 2016, are easier for caregivers to administer and for children to take. The

South African study finds no difference in HIV risk among implant users

A pivotal clinical trial to address a long-standing question about the relationship between hormonal contraceptive use and the risk of HIV acquisition has found no substantial difference in HIV risk among 7,829 African women who were randomly assigned to use one of three highly effective methods of contraception. Designed to provide high-quality evidence to help

Top